Should Ambulatory Patients with Cancer Receive Anticoagulation for VTE Prophylaxis During Systemic Chemotherapy?
Patients with cancer, including: • Hospitalized patients • Patients without venous thromboembolism (VTE) receiving chemotherapy on an ambulatory basis • Patients undergoing surgery (perioperative and postoperative periods) • Patients with recent prior VTE • Patients without an established VTE more.
I cant really gove you an answer,but what I can give you is a way to a solution, that is you have to find the anglde that you relate to or peaks your interest. A good paper is one that people get drawn into because it reaches them ln some way.As for me WW11 to me, I think of the holocaust and the effect it had on the survivors, their families and those who stood by and did nothing until it was too late.
Related Questions
Should Patients with Cancer Undergoing Surgery Receive Perioperative VTE Prophylaxis?
What forms of VTE prophylaxis comply with the VTE measure?
Epidural anesthesia is commonly and appropriately used in patients at varying levels of VTE risk. What interventions and recommendations exist to minimize the risk of bleeding in these patients?
Is there data or rationale for overlapping warfarin with LMWH, UFH, or fondaparinux for VTE prophylaxis post hip or knee orthopedic surgery?
Do patients followed in anticoagulation clinics for antiphospholipid syndrome meet criteria for the disorder?
Are physicians who practice in hospital-based ambulatory clinics eligible to receive Medicare or Medicaid EHR incentive payments?